预测帕金森病的门诊能力,以分析进展,生物标志物和试验设计
Charles S Venuto1,2, Greta Smith1, Konnor Herbst1
1Center for Health + Technology, University of Rochester, Rochester, New York, USA.
概括
使用临床数据预测帕金森病的进展,可以准确地识别出行走和平衡恶化的个体. 这有助于了解疾病的发展轨迹,并优化临床试验设计,以获得更好的结果.
科学领域:
- 神经学 神经学
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
背景情况:
- 帕金森病 (PD) 显著损害了步态和平衡,导致跌倒和残疾.
- 目前的治疗方法对这些运动症状的疗效有限.
- 需要预测模型来理解步态/平衡障碍,并改进临床试验设计.
研究的目的:
- 使用基线临床数据预测早期帕金森病的门诊能力轨迹.
- 将这些预测的轨迹与临床里程碑和生物标志物相关联.
- 评估这些轨迹在丰富临床试验方面的潜力.
主要方法:
- 利用两项纵向观测研究的数据进行模型培训和外部验证.
- 开发了一种支向量机器模型,用于将个人分类为"进步"或"稳定"的门诊轨迹.
- 使用生存分析来比较预测轨迹之间的临床里程碑和试验结果.
主要成果:
- 在外部验证中,预测模型获得了0.735的准确性和0.799的加权F1得分.
- 在"进步"轨迹中的个人在4年内更有可能出现平衡,独立,功能和认知障碍.
- 在轨迹组之间观察到多巴胺载体成像和神经退行生物标志物的显著差异.
- 用"渐进"的轨迹丰富18个月的临床试验,可以节省高达30%的样本大小.
结论:
- 临床数据可以有效地预测早期帕金森病的门诊能力.
- 这些预测与显著的临床结果相关,可以为疾病的理解提供信息.
- 轨迹预测为优化临床试验设计和效率提供了有价值的工具.
相关概念视频
01:24Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
01:15Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607